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ABSTRACT
B cell subpopulations in the spleen have been extensively characterized phenotypically; however, biochemical properties of these 
cell populations following B cell antigen receptor engagement have not been fully determined due to technical difficulties and 
limiting cell numbers. We therefore employed mini-scale protocols to assess lipid signaling, particularly that of diacylglycerol and 
inositol trisphosphate, with as few as 0.5x10
6 purified early (T1) and late (T2) transitional B cells. Additionally, utilizing flow 
cytometric techniques, we determined levels of phosphatidylinositol bisphosphate and calcium mobilization in T1 and T2 cells, as 
well as mature follicular and marginal zone B cells using less than 1x10
6  primary B cells. Thus, these biochemical and flow 
cytometric   methodologies   can   be   used   to   analyse   signal-induced   changes   in   phosphatidylinositol   bisphosphate   levels, 
diacylglycerol and inositol triphosphate production and calcium in each B cell population.
INTRODUCTION
The B cell compartment within the mouse spleen is comprised 
of at least five subpopulations, including immature transitional 
type 1 (T1), transitional type 2 (T2) and T2-preMZ, as well as 
mature Follicular (Fo) and marginal zone (MZ) B cells (1-4). 
Signaling through the B cell antigen receptor (BCR) is required 
for the generation of a functional mature B cell repertoire (3, 5), 
and multiple components of the BCR signalosome regulate 
biochemical events after BCR engagement. Upon activation by 
Btk, PLC-γ2 catalyzes the hydrolysis of phosphatidylinositol 
bisphosphate (PtdInsP2 or PIP2) into the two second messengers, 
inositol trisphosphate (IP3), which activates Ca
2+ signaling, and 
diacylglycerol (DAG), which activates  protein kinase C (PKC) 
signaling pathways (6, 7). It  is well established that both 
calcium and PKC signaling are important in B cell survival and 
development/maturation, as well as proliferation (8, 9). Thus, 
quantities   of  PIP2,   DAG   and   IP3  are   likely   to   direct   the 
subsequent signaling events leading to the fate of developing B 
cells. Developing new protocols to study lipid signaling is 
therefore   a   prerequisite   for   understanding   the   molecular 
mechanisms underlying the generation of mature B cells. 
Because only a small number of each B cell subpopulation can 
be obtained by flow cytometry-based cell sorting methods, we 
developed and optimized mini-scale DAG and IP3 quantification 
protocols in order to analyze the levels of DAG and IP3 within 
transitional B cell subsets following BCR cross-linking. These 
protocols allowed the quantification of lipid species utilizing as 
few as 0.5-5x10
6 purified B cells. Additionally, utilizing flow 
cytometry (FCM) techniques to identify B cell populations, we 
analyzed PIP2 levels and calcium mobilization in transitional and 
mature B cell subsets, again using as few as 1x106 total B cells. 
Here we report the detailed experimental procedure of micro-
scale flow cytometry and biochemical analysis of lipid signaling 
in primary B cells. 
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MATERIALS AND METHODS
Mice and B cell purification
Wild type C57BL/6 mice (Jackson Laboratories, Maine, USA) 
were used. All mice that were used as the source of splenocytes 
were treated humanely in accordance with federal and state 
government guidelines and their use was approved by the 
institutional animal committee.
Primary  B   lymphocytes   were   isolated   from   single   cell 
suspensions pooled from the spleens of C57BL/6 mice. Cell 
suspensions were depleted of RBCs, and B lymphocytes were 
purified through magnetic sorting on an AutoMACS automated 
cell sorter (Miltenyi Biotech) by negative selection (CD43-
depletion) to avoid B cell activation. The purity of B cells 
isolated in this manner was approximately 90–95% as verified 
by FCM analysis using anti-B220 and anti-IgM antibodies 
(Pharmingen,   USA).   FACS-sorting   for   highly   purified 
transitional   B   cell   subsets   was   performed   as   previously 
described (2).
Lipid analysis
PIP2  quantitation:  PIP2  levels following anti-IgM  stimulation 
were monitored by flow cytometry. MACS-enriched B cells 
were resuspended (10x10
6  cells/ml) in complete RPMI-1640, 
rested on ice for 1.5 hours, and incubated for 15 minutes at 37°C 
prior to assay. Cells were then stimulated with 20 μg/ml goat 
anti-mouse IgM F(ab’)2 antibodies (Jackson ImmunoResearch) 
for the indicated times, and immediately fixed (in order to 
preserve PIP2  phosphorylation status) by harvesting 100 μl 
(containing   1x10
6  cells)   into   1   ml   cold   PBS   +   2% 
paraformaldehyde at each time-point. Cells were permeabilized 
utilizing the Cytofix/Cytoperm kit (BD Biosciences) according 
to the manufacturer’s instructions, and intracellularly labeled 
with a biotinylated antibody raised against PI(4,5)P2 (Z-B045; 
Echelon Biosciences, Inc; 1:500 dilution) for 20 minutes on ice. 
Cells were then washed and labeled with APC-conjugated anti-
CD19 (clone 1D3; 1:100 dilution), FITC-conjugated anti-HSA 
(clone M1/69; 1:500 dilution), and PE-conjugated anti-CD21 
(clone 7G6, 1:400 dilution) for the identification of splenic B 
cell subsets, and PerCP-Cy5.5-conjugated streptavidin (1:300 
dilution) to visualize PIP2. Anti-C1qRp (AA4.1) and anti-CD23 
antibodies were not utilized due to non-reactivity with B cells 
that have undergone fixation. Following a 20 minute incubation 
on ice, cells were washed, and resuspended in 100 μl FACS 
buffer (2% FBS in PBS), followed by 100 μl fix buffer (2% 
paraformaldehyde in FACS buffer) to preserve the cells. To test 
the specificity of the anti-PIP2 antibody, freshly isolated MACS 
enriched B cells were fixed and permeabilized as described 
above,   then   intracellularly   labeled   with   an   anti-PIP2-FITC 
antibody (Z-G045; Echelon Biosciences, Inc; 1:300 dilution) 
that had been pre-incubated with varying concentrations of PIP2 
liposomes (Y-P045 (biotinylated); Echelon Biosciences, Inc) for 
15 minutes on ice. Data was acquired on a BD FACSCalibur or 
BD LSRII flow cytometer. Results are expressed as MFI and are 
representative of multiple experiments. 
DAG   quantification:  Purified   B   cells   were   labeled   with 
[
3H]palmitic   acid   (2.5   mCi/ml),   as   a   fatty  acid   precursor. 
Labeled B cells were washed twice with PBS, incubated for 
various time periods or stimulated through the BCR with goat 
anti-mouse IgM F(ab')2 as indicated. The reactions were stopped 
by the addition of excess cold PBS. The cells were pelleted by 
centrifugation and used for lipid extraction. The pellet was 
suspended in 2 ml chloroform-methanol (2:1 v/v) and 0.4 ml of 
0.5 N HCl was added. The mixture was shaken vigorously, 
centrifuged, and the upper (aqueous) phase was discarded while 
the lower (organic) washed twice with theoretical upper phase 
(10). The radioactivity of lipids was determined on an aliquot 
fraction by scintillation counting. Dipalmitin carrier standard 
was then added, the lipid phase evaporated gently under a N2 
stream and the residue dissolved in a minimum volume of 
chloroform-methanol (2:1 v/v). DAG was separated by thin 
layer chromatography on silica gel G plates using a double 
development system and detected under UV light after spraying 
the plates with primulin as previously described (11). The area 
containing DAG was scraped and the radioactivity determined 
as previously described (6, 11, 12).
[
3H]-Inositol   labeled   soluble   inositol   polyphosphate   (IP) 
profiling: The soluble IP profile for B cells was determined by 
adapting a previously described protocol (13). Briefly, MACS-
enriched   total   B   cells   or   FACS-purified   B   cell   subsets 
(10x10
6/ml) were cultured in inositol-free DMEM containing 60 
mCi [
3H]Inositol/ml (Perkin Elmer) for 4 hours. Cells were 
harvested, washed twice with 1 ml PBS and suspended in PBS 
(10x10
6/ml). 100 μl cell aliquots (containing 1x10
6 cells) were 
treated with 25 μl PBS with or without 20 μg/ml goat anti-
mouse IgM F(ab’)2. Treatments were stopped by adding 6.6 μl 
10 N HCl and chilling cells on ice. Soluble IPs were extracted 
by adding 465 μl of chloroform/methanol (1:2 v/v). The mixture 
was vortexed for 2 minutes at maximum speed, followed by 
addition of 156 μl each of chloroform and 2 M KCl and another 
2 minutes of vortexing. The lysate was spun at 13,000 g for 5 
minutes and the supernatant recovered. Samples were analyzed 
by the HPLC (Shimadzu Corporation) connected to the Radio-
HPLC Detector (IN/US Systems, Inc.). The IPs were resolved 
by a Whatman partisphere SAX strong-anion exchange column 
(4.6 x 125 mm) and a linear gradient from 10 mM to 1.7 M 
ammonium phosphate (pH 3.5) for 25 minutes, followed by 
elution with 1.7 M ammonium phosphate for 20 minutes. 
Calcium mobilization in B cell subsets: MACS-enriched B cells 
were resuspended (10x10
6 cells/ml) in warm HBSS w/o phenol 
red, and loaded with indo-1-AM (5 μg/ml) for 30 minutes at 
37°C. Cells were then washed, resuspended (20x10
6 cells/ml) in 
FACS buffer, placed on ice, and labeled for 20 minutes with PE-
conjugated anti-HSA (clone M1/69; 1:750 dilution), biotinylated 
anti-CD23 (clone B3B4; 1:200 dilution) which was visualized 
by PerCP-Cy5.5-conjugated streptavidin (1:200 dilution), and 
APC-conjugated anti-C1qRp (clone AA4.1; 1:100 dilution) for 
B cell subset identification. Antibodies raised against B220, 
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CD19, and/or CD21 were not used in order to avoid inadvertent 
stimulation of B cells. Following labeling, cells were washed, 
resuspended (1x10
6/ml) in HBSS containing 1 mM calcium, and 
kept on ice until assay. Prior to acquisition, cells were warmed 
for 15 minutes in a 37°C water bath, and applied to a BD LSR II 
cytometer. Baseline, non-stimulated measurements were taken 
for 90 seconds, followed by the addition of 10 μg/ml goat anti-
mouse IgM F(ab’)2 antibodies for the indicated time. Ionomycin 
(1 mM) was used as a positive control to ensure that cells were 
competent to release calcium from intracellular stores. Data is 
expressed   as   a   ratio   of   Indo1-violet/Indo1-blue,   and   is   a 
representative of multiple experiments.
Statistics 
The data represent the mean of at least three experiments 
analyzed utilizing Student's t-test.
RESULTS 
PIP2 hydrolysis occurs in all B cell subsets as determined 
by FCM 
Because PIP2 serves as a substrate for PLC-γ2 in the production 
of DAG (14), we wanted to determine basal and BCR-induced 
levels of PIP2 in all B cell subsets. MACS-enriched splenic B 
cells were stimulated, harvested, and immediately fixed in 2% 
paraformaldehyde  in  order  to  preserve  the  phosphorylation 
status of PIP2. Cells were then stained intracellular for PIP2 and 
extracellular with a combination of anti-HSA, anti-CD21, and 
anti-CD19 antibodies for B cell subset identification. Utilizing 
flow cytometric analysis, CD19
+ cells were displayed with HSA 
and CD21 in order avoid inclusion of any remaining non-B cells 
in   the   analysis   (Fig.   1A).   CD21
hi  MZ   and   pre-MZ   were 
separated   based   on   differential   HSA   expression,   which 
corresponded to CD23 expression (preMZ are HSA
hiCD23
+, MZ 
are HSA
midCD23
lo), as we previously reported (2). Basal PIP2 
levels were then measured in each subset (Fig. 1B). In addition, 
we determined the kinetics of BCR-induced PIP2 production in 
each B cell subpopulation following stimulation with 20 μg/ml 
anti-IgM F(ab’)2 antibodies. In all splenic B cell subsets, PIP2 
levels were reduced immediately in response to stimulation with 
anti-IgM, indicative of PIP2 hydrolysis (Fig. 1C).
Optimal lipid labeling with [
3H]palmitic acid is achieved 
in 6 hours
To   analyze   the   lipid   synthesis   and   BCR-directed   DAG 
production in wild type primary B cells, we systematically 
assessed the numbers of primary B cells and the amount of 
radioactivity required for optimum labeling.  MACS-enriched 
total splenic B cells or FACS-sorted B cell subsets were used 
immediately for labeling with [
3H]palmitic acid, a saturated fatty 
acid (6). Pilot experiments indicate that optimal lipid synthesis 
is achieved with a concentration of 2.5 mCi/ml (data not 
shown).   Using   this   information,   we   discovered   that   the 
incorporation of radioactivity was detectable after 30 min, 
increased in a time-dependent manner reaching a plateau at 6 h, 
and remained unchanged through 24 h ( Fig. 2A). The same 
profile was obtained when the results were expressed as cpm/mg 
protein indicating a dynamic process (data not shown). 
BCR-induced DAG production is dose-dependent and can 
be detected with as few as 0.5x10
6 B cells
MACS-enriched   total   B   cells   were   labeled   for   6   h   with 
[
3H]palmitic acid, then were stimulated for 5 minutes with 
various   concentration   of   anti-IgM   antibodies   in   order   to 
determine   the   production   of   DAG   (12).   DAG   production 
increases in a dose dependent manner and is optimal at 20 μg/ml 
of anti-IgM (Fab’)2 (Fig. 2B).
To test the feasibility of DAG quantification experiments with 
small numbers of primary B cells, we labeled MACS-enriched 
total B cells for 6 h with [
3H]palmitic acid, and determined its 
incorporation into whole lipids in various numbers of B cells. 
We observed a strong correlation between the total radioactivity 
detected in whole lipids with the number of B cells labeled (r = 
0.998). It is noteworthy that the radioactivity was close to 50000 
and 100000 cpm for 0.5x10
6 and 1x10
6 labeled cells respectively 
(Fig. 2C). Since the level of DAG represents 0.6% of total lipids 
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Fig. 1A & 1B:  PIP2  is hydrolyzed in all B cell subsets 
following anti-IgM stimulation. (A) : Freshly isolated MACS-
enriched  wt  B  cells   were  fixed  with  2%  paraformaldehyde, 
permeabilized   and   labeled   with   antibodies   directed   against 
CD19, CD21, and HSA for B cell subset identification. (B):  B 
cells from (A) were examined for basal PIP2 levels utilizing an 
anti-PI(4,5)P2  antibody.   Data   is   an   example   of   multiple 
experiments.76
extracted from the mouse primary splenic B cells (2), the 
amount of [
3H]DAG in 0.5x10
6 B cells should be close to 500 
cpm which is more than 100 times greater than the background, 
and   should   therefore   allow   reliable   estimation   of   DAG 
production. 
We next determined the level of BCR-induced DAG production 
after 5 minutes of stimulation with anti-IgM (20 μg/ml) using 
various numbers of MACS-enriched total B cells ranging from 
0.5x10
6 to 5x10
6. The results show that upon BCR ligation the 
profile of DAG production obtained from a small number 
(0.5x10
6) of primary B cells coincides  precisely with that 
obtained from a large number (5x10
6) of B cells (Fig. 2D). 
When 0.5x10
6 B cells were labeled with [
3H]palmitic acid, the 
radioactivity detected in DAG was similar to that calculated 
from the standard curve (450 cpm corresponds to 0.5% of total 
lipids). Therefore, lipid signaling in transitional B cell subsets 
may be investigated using [
3H]palmitic acid as the radioactive 
labeling precursor. In this regard, we previously demonstrated 
that BCR-mediated DAG production occurs in T2 and mature B 
cells following both 5 min (2.1- ± 0.1-fold increase, and 5.1-  ± 
0.3-fold   increase,   respectively,   compared   with   the   non-
stimulated  control) and 30 min (2.8- ± 0.3-fold increase, and 
4.8- ± 0.4-fold increase, respectively, compared with the non-
stimulated control) stimulation with anti-IgM (2). In contrast, T1 
B   cells   did   not   produce   DAG   in   response   to   anti-IgM 
stimulation (2).
HPLC analysis of BCR-induced IP3 production in splenic B 
cell subsets 
Because we observed significant differences in BCR-mediated 
DAG   production   in   transitional   B   cell   subsets,   we   also 
investigated   the   production   of   IP3  in   response   to   BCR 
stimulation utilizing HPLC. Using MACS-enriched total B cells, 
we first performed a kinetics study and determined that 1 minute 
of anti-IgM stimulation was the optimum time-point for IP3 
detection (Figure 3A and B). We then utilized 1x106  FACS-
purified  transitional T1  and T2  B  cells  to  investigate IP3 
production following anti-IgM stimulation. T2 B cells produced 
significantly more IP3 than T1 B cells (1.52 ± 0.5-fold increase 
and 3.09 ± 0.2-fold increase, respectively; n = 3) (Figure 3 C-E), 
consistent with the previously observed DAG production profile 
(2). 
FCM analysis of intracellular Ca
2+ mobilization in B cell 
subsets 
Because   the   generation   of   IP3  subsequently   induces   Ca
2+ 
mobilization in primary  wt  B cells (15), we next wanted to 
investigate calcium mobilization in B cell subsets. To precisely 
define stage-specific calcium mobilization within B cell subsets, 
we utilized FCM techniques. 1x10
6  MACS-enriched B cells 
were loaded with indo-1-AM and labeled with a combination of 
anti-C1qRp (AA4.1), anti-HSA and anti-CD23 antibodies for B 
cell subset identification (Fig. 4A). Antibodies directed against 
B220, CD19, and CD21 were not used in order to avoid 
inadvertent   B   cell   activation.   Cells   were   applied   to   the 
cytometer, baseline measurements taken for 60-90 seconds, then 
stimulated with anti-IgM for the indicated times. From the AA4
+ 
gate, T1 (HSA
hiCD23
-) and T2 (HSA
hiCD23
+) cells were gated 
for calcium analysis. The vast majority of T2-preMZ cells do 
not express AA4.1; therefore they are excluded from T2 cells 
gated   in   this   manner.   From   the  AA4-   gate,   mature   FoB 
(HSA
loCD23
+) and MZ (HSA
midCD23
lo) were gated for calcium 
analysis. Our results demonstrate that calcium mobilization can 
be   monitored   in   all   B   cell   subsets   following   anti-IgM 
stimulation, using as few as 1x10
6  MACS-enriched, FACS-
stained total B cells (Fig. 4B).
DISCUSSION
The goal of this study was to develop protocols to assess 
Antony et al. – Micro-scale flow cytometry-based and biochemical analysis of lipid signaling in primary B cell subpopulations
www.biologicalprocedures.com
Fig. 1C & 1D:  PIP2  is hydrolyzed in all B cell subsets 
following anti-IgM stimulation. (C): B cells were stimulated 
for the indicated times with 20 μg/ml anti-IgM, immediately 
fixed and permeabilized, then labeled and examined for PIP2 
levels as in (B); T1 (filled diamonds), T2 (filled squares), mature 
FoB (open circles), preMZ (filled triangles), mature MZB (open 
triangles). Data is displayed as the average MFI of duplicate 
samples, and is a representative of at least 4 experiments. (D): 
The specificity of the anti-PIP2  antibody was tested by pre-
incubation of the antibody with PIP2 liposomes for 15 min prior 
to intracellular labeling of MACS-enriched total B cells as in (B). 77
dynamic changes  in  lipid  signaling in  each  B  cell  subset 
following antigenic stimulation. By utilizing FCM techniques to 
assess both PIP2 levels and calcium mobilization in individual B 
cell subsets, we eliminated the necessity for purification of B 
cell subsets in these analyses. Additionally, we defined optimal 
conditions to rapidly analyze DAG and IP3 production utilizing 
numbers of total primary B cells similar to the quantities of 
transitional B cells that can be obtained by magnetic bead and 
FCM based cell sorting protocols (2, 16).
In this report we used a combination of the most current staining 
schemes to identify B cell subpopulations in the spleen by FCM 
(1-4, 16, 17). We have combined extracellular staining for B cell 
subset identification  with intracellular  staining  protocols in 
order to determine PIP2 levels in all B cell subsets following 
stimulation with anti-IgM (Fig. 1). It is important to note that 
following an initial period of BCR-induced PIP2  hydrolysis, 
BCR-induced   PIP2  production   occurs   in   all   the   B   cell 
subpopulations (Fig. 1C). This increase in PIP2 over time may 
result from DAG conversion into PIP2  or PIP2  synthesis by 
PIP5K following BCR stimulation (18, 19). Thus, a PIP2 cycle is 
activated in B cells in response to BCR cross-linking. The lower 
production   of   DAG   and   IP3  in   T1   B   cells   suggests 
developmental stage-specific mechanisms of PIP2  cycling in 
splenic B cell subpopulations. Additionally, it is noteworthy that 
the B cell subset with the lowest baseline (mature FoB) had the 
greatest changes in PIP2 MFI while the B cell subsets with the 
highest baselines (T2 and preMZ) had the smallest changes in 
PIP2 MFI (Fig. 1C), indicating that the inducible production of 
PIP2 through BCR stimulation is tightly associated with its basal 
level. As we have previously shown for PKC phosphorylation 
(2), this protocol can be extended to study other intracellular 
biochemical signaling events following antigenic stimulation.
In addition, we have employed FCM techniques in order to 
assess calcium mobilization in B cell subsets. Again, employing 
a unique combination of antibodies, which identify B cell 
subsets but will not activate cells inadvertently, we monitored 
calcium mobilization in each B cell subset following antigenic 
stimulation using as few as 1x10
6 MACS-enriched B cells and 
found that all B cell subsets mobilize calcium following anti-
IgM stimulation (Fig. 4). These FCM-based techniques use only 
minimal numbers of primary B cells, and eliminate the need for 
FACS-based cell sorting of individual B cell populations.
We also report that 
3[H]palmitic acid can be used to efficiently 
label lipids in primary splenic B cells. We observed that peak 
radioactivity is reached after 6 h of labeling (Fig. 2A). Since 
splenic B cells die rapidly  in vitro  in the absence of B cell 
growth factors and/or agonists, the relatively short duration of 
labeling (6 h) with 
3[H]palmitic acid minimizes the loss of B 
cells (16, 17). Our results also show that lipid levels can be 
determined   with   small   numbers   of   B   cells,   and   that   the 
radioactivity incorporated into lipids in 0.5x10
6 B cells is close 
to 5x10
4 cpm (8000 times higher than the background) which 
should allow easy quantification of lipid species (Fig. 2C). 
These   data  are  in   agreement   with   studies   performed   with 
primary B cells labeled with [
3H]arachidonic acid (15), both in 
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Fig.   2:  Lipid   synthesis   and   DAG   production   in   small 
numbers of primary B cells. (A): Kinetics of lipid synthesis in 
primary B cells. Incorporation of [
3H]palmitic acid (2.5 mCi/ml) 
into lipids was determined in purified wt primary B cells. Lipid 
extraction was performed according the protocol of Folch (10). 
Lipid synthesis is expressed in cpm and represents the average 
+ SEM of three independent performed in triplicate. (B): BCR-
induced DAG production is dose dependent. 5x10
6  purified B 
cells were labeled for 6h with [
3H]palmitic acid (2.5 mCi/ml) and 
stimulated for 5 min with various doses of anti-IgM. Lipids were 
extracted   and   separated   as   described   (12)   and   DAG   was 
quantified. DAG is expressed as percentage increase of DAG of 
total radioactivity and represents the average + SEM of three 
independent performed in triplicate. *P<0.05; ***P<0.001.  (C): 
[
3H]palmitic   acid   is   incorporated   into   whole   lipids   in   small 
numbers of primary B cells. The indicated numbers of non-
stimulated   B  cells   from   wt   mice   were   labeled   for   6h   with 
[
3H]palmitic   acid   (2.5   mCi/ml)   and   total   incorporation   of 
[
3H]palmitic   acid   into   lipids   (r=0.998)   was   monitored   as 
described   (6).  (D):  BCR-induced   DAG   production   can   be 
measured in as few as 0.5x10
6  primary B cells. The same 
protocol as in (B) was applied to 0.5-5x10
6 primary B cells that 
were   stimulated   for   5   minutes   with   20   μg/ml   of  anti-IgM. 
***P<0.001.78
the   profile   of   DAG   accumulation   and   the   quantity   of 
radioactivity.
An alternate enzymatic method for the quantification of DAG 
employed an Escherichia coli DAG kinase which catalyzes the 
production of [
32P]phosphatidic acid from DAG substrate (20). 
This radiosensitive assay was successfully developed for sn-1,2 
diacylglycerols quantification. Moreover, the DAG kinase assay 
was already applied to Epstein-Barr virus negative Burkitt's 
lymphoma Ramos cells to quantify ceramide (21). Here,  our 
lipid   separation   method   allows   the   separation   of   sn-1,2 
diacylglycerol from sn-1,3 diacylglycerol species, and the DAG 
level reflects that of both isomers (12). In addition, we were able 
to   quantify   other   neutral   lipid   species   (palmitic   acid, 
mLtriglycerides, and monoglycerides) in one single experiment 
(data not shown).
Development of immunocompetent B-lymphocytes is critically 
dependent on signaling through the BCR (5). Our results show 
that while 20 μg/ml of anti-IgM (Fab’)2  antibodies induces 
maximal   production   of   DAG,   lower   doses   also   lead   to 
significant production of DAG (Fig. 2B).
We also demonstrate that in response to BCR cross-linking, an 
increase in DAG production is clearly detectable with as few as 
0.5x10
6  B cells (Fig. 2D). We have previously employed the 
methods described in this report to determine DAG production 
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Fig. 3A & 3B: Generation of IP3  in primary B cells:  A) 
Timecourse of IP3  production in primary B cells. 3x10
6  MACS-
enriched B cells were labeled with 
3[H]inositol (60 mCi/ml) for 4 
h, then incubated with PBS (non-stimulated) or stimulated with 
20 μg/ml anti-IgM for the indicated times. Production of soluble 
IP   species   was   measured   by   HPLC   and   the   position 
corresponding to each species is indicated. IP3 production was 
measured as the total counts detected within the 14.25-15.25 
minute time window. HPLC profile of an  ipk1-5  mutant yeast 
strain (26) serves as reference. (B): IP3 production from the B 
cells   in   (A)   is   expressed   as   the   counts   in   the   position 
corresponding to IP3.
Fig. 3C – 3E:   Generation of IP3 in primary B cells: (C): 
1x10
6  FACS-purified  wt  T1 and T2 B cells were labeled with 
3[H]inositol as in (A) and stimulated with 20 μg/ml anti-IgM for 1 
minute.   IP3  production   was   detected   as   in   (A).   Data   is   a 
representative   of   four   independent   experiments.  (D):  IP3 
production from the T1 and T2 B cells in (C) is expressed as the 
counts in the position corresponding to IP3. E) Fold change in IP3 
level from T1 and T2 B cells following stimulation with anti-IgM 
was   calculated   from   the   counts   measured   in   the   position 
corresponding to IP3 as in (C and D) (n=3).79
following anti-IgM stimulation in 1x10
6 FACS-purified T1, T2 
and mature FoB cells (2). In that study, we reported that T2 and 
FoB cells rapidly produce detectible levels of DAG following 
anti-IgM   stimulation   and   that   increased   DAG   levels   are 
maintained for a significant period of time, while T1 B cells do 
not   produce   DAG   at   any   time-point   following   anti-IgM 
stimulation (2).
After we observed that DAG was differentially produced in 
transitional B cells subsets, we wanted to confirm that IP3 
production followed a similar pattern, as these two lipids are 
both by-products of PIP2  hydrolysis. Consistent with DAG 
production, IP3 was detected by HPLC in total B cells and in 
purified T2 B cells, but not in purified T1 B cells (Fig. 3 A and 
C). In addition to IP3, we found that levels of other IPs (i.e., IP1, 
IP2, IP4, and IP5) also change in all B cell populations, however, 
these changes are most apparent in total B cells (Fig. 3A). This 
observation   may   reflect   more   robust   changes   in   mature 
follicular   B   cells,   which   is   the   predominant   population 
(approximately 60-70%) in splenic B cells. Thus, the magnitude 
of BCR-induced IP3 production is likely to be underestimated 
because IP3 can undergo additional phosphorylations by kinases 
to generate IP4, IP5 IP6. These findings also raise the possibility 
that other IPs may also play distinct roles in modulating B cell 
physiology. Indeed, a previous report showed that the PH 
domain of Btk functions as an inositol 1,3,4,5-tetrakisphosphate 
(IP4), inositol 1,3,4,5,6-pentakisphosphate (IP5), and inositol 
1,2,3,4,5,6-hexakisphosphate (IP6) binding domain and that xid 
mutations (R28C) found in the Pleckstrin Homology domain 
result in a dramatic reduction of IP4  binding activity (22). 
Consistent with these results, BCR-induced DAG/IP3 production 
is Btk dependent, suggesting that B cell differentiation is likely 
to be correlated with the IP4 binding capacity of the PH domain 
of Btk (2, 22, 23). Additionally, a recent report revealed that 
inositol 1,4,5-triphosphate 3-kinase and its reaction product IP4 
are both required to mediate survival signalling in B cells via a 
Ras-ERK signalling pathway that controls the expression of the 
proapoptotic protein, Bim (24).
Together,   these   results   demonstrate   our   ability   to   perform 
experiments   to   determine   BCR-dependent   lipid   signaling 
utilizing the small numbers of B cells that are obtained with any 
of the B cell subpopulation purification protocols we have 
previously published (2, 16). Additionally, while these protocols 
were established in cells that were stimulated through the BCR, 
it is reasonable to believe that these protocols will be useful 
when monitoring B cell activation by many different cellular 
stimuli; in fact, we have already utilized these protocols to 
monitor   DAG   and   IP3  production,   as   well   as   calcium 
mobilization, in B cells stimulated with BAFF (25). Thus, the 
protocols   that   we   describe   in   this   report   should   allow   a 
comprehensive determination of differential lipid signaling and 
signal transduction in primary B cell populations in response to 
various stimuli.
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PROTOCOLS
B cell purification by negative selection
Materials: 
FACS buffer (PBS + 2% FBS)
MACS buffer (PBS + 0.5% BSA and 1mM EDTA)
Complete RPMI (RPMI + 10% FBS, 4mM L-glut, 100U P/S, 0.1% 2-ME, 10mM HEPES)
* anti-mouse CD43 magnetic beads (130-049-801 Miltenyi Biotech)
* AutoMACS automated cell sorter or MiniMACS columns (Miltenyi Biotech)
** B-cell enrichment kit (557792 BD Biosciences) and manual IMAG magnet 
1) Harvest the spleen from a wt C57BL/6 mouse.
2) Isolate splenocytes by smashing spleen in a 70 mM cell strainer with 5ml PBS. Transfer cells to a 15ml conical tube and 
rinse strainer 2X with 5ml PBS. Transfer washes to the tube with cells and centrifuge for 6 minutes at 1600 rpm at 4°C.
3) Aspirate supernatant and lyse RBC, while vortexing, by the addition of 900 μL sterile filtered ddH20 followed 
immediately by the addition of 100 μL 10x PBS. Remove floating fat, and add FACS buffer to 10 ml.
4) Count cells.
5) Centrifuge cells for 6 minutes at 1600 rpm at 4°C. Resuspend cells at 100x10
6/ml in MACS buffer.
6) *Add anti-CD43 beads and incubate according to the manufacturers instructions.
7) *Sort cells on the AutoMACS using the DelpeteS cycle or on the MiniMACS magnetic columns according to the 
manufacturers directions.
8) Resuspend CD43-negative cells in 1-2 ml of complete RPMI and count cells. 
9) Stain a small aliquot for purity with anti-B220 or anti-CD19, and analyze by FCM.
** 6-7)  Alternatively, B cells can be enriched using the B cell enrichment kit and manual magnet from BD according to 
the manufaturers instructions.
PIP2 quantitation by FCM
Materials: 
Stop buffer (PBS + 2% paraformaldehyde)
BD Cytofix/Cytoperm kit
Fix buffer (FACS + 2% paraformaldehyde)
*Biotinylated anti-PIP2 antibody (Z-B045; Echelon Biosciences)
Anti-HSA-FITC antibody (BD clone M1/69)
Anti-CD21-PE antibody (BD clone 7G6)
*SAv-PerCP-Cy5.5 (BD 551419) 
Anti-CD19-APC antibody (BD clone 1D3)
*anti-PIP2-FITC (Z-G045; Echelon Biosciences)
1) Resuspend MACS-enriched B cells in RPMI (10x10
6/ml) and rest on ice for 1hr.
2) Warm cells in a 37°C water bath for 15 minutes
3) Prepare “Stop” tubes (1ml stop buffer) for each time point
4) Harvest Time 0 sample by collecting 100 μl (1x10
6 cells) into the appropriate stop tube (harvest an extra sample if staining 
with an isotype control)
5) Stimulate cells for desired time with anti-IgM F(ab’)2
6) Harvest cells by collecting 100 μl at each desired time point into appropriate stop tubes
7) Centrifuge 1700 rpm for 4 minutes
8) Fix/permeabilize using BD Cytofix/cytoperm kit according to manufacturer’s instructions
9) *Intracellular stain with anti-PIP2-biotin (1:500) in 100 μl perm-wash buffer/1x10
6 cells for 20 minutes. Wash with 1ml 
perm-wash, and spin at 1700 rpm for 4 minutes.
10) *Stain intracellular with SAv-PerCP-Cy5.5 (1:300), and extracellular with anti-HSA (1:500), anti-CD21  (1:250),   and 
anti-CD19 (1:100) in 100 μl perm-wash buffer/1x10
6 cells for 20 minutes. Wash with 1ml perm-wash, and spin at 1700 
rpm for 4 minutes.
11) Resuspend cells in 100μL FACS + 100 ml Fix.
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12) Acquire data on FACS machine.
** 9-10) Alternatively, anti-PIP2-FITC (1:300) can be used to study PIP2 levels in total B cells (for subset  identification, 
use in combination with HSA-PE (1:500), CD19-PerCP-Cy5.5 (1:200), and CD21-APC (1:400); all from BD)
DAG quantification by TLC
1) Resuspend purified B cells in complete RPMI, and label cells with 2.5 mCi/ml [
3H]palmitic acid (Sigma) for 6 hours at 
37°C, 5% CO2.
2) Spin cells at 2000 rpm for 5 minutes.
3) Remove supernatant
4) Wash cells twice with RPMI without serum 
5) Resuspend cells (3x10
6/ml) in PBS in glass tubes and warm to 37°C .
6) Incubate cells with 20 μg/ml anti-IgM F(ab’)2 for appropriate times at 37°C.
7) Stop reactions by adding 1 ml cold PBS
8) Spin the cells at 3000 rpm for 5 minutes and wash twice with PBS
9) Remove supernatant
10) Extract lipids with 2 ml of a mixture of cold chloroform:methanol (2:1, v:v)
11) Place the samples at 4 °C overnight
12) Add 400 μl HCl (0.5N) to the 2 ml sample
13) Vortex tubes for 10 seconds
14) Spin at 3000 rpm for 5 minutes at 4°C 
15) Take 10 μl of the upper phase and count the radioactivity in scintillation counter to ensure that after washing the cells no 
radioactivity remains in the aqueous phase. Presence of radioactivity in the aqueous phase will indicate poor lipid 
labelling and the experiment should be discarded.
16) Remove the upper phase
17) Transfer 1 ml of the organic phase to a new glass tube
18) Remove 10 μl of the organic phase and count the radioactivity in scintillation counter
19) Add 40 μl of cold carrier lipids (mixture of phosphatidic acid, monoglycerides, 1-2 dipalmitin, palmitic acid, tripalmitin, 
each at 10 mg/ml; Sigma)
20) Evaporate the organic phase gently under an N2 stream
21) Resuspend the residue in 40 μl chloroform-methanol (2:1, v:v)
22) Load on a 20x20 cm Silica Gel plate (Merck)
23) Separate neutral lipids from the other lipids in the upper phase with a mixture of ethylacetate:isooctane:acetic acid:water 
(130:20:30:100)
24) Allow the TLC to run half-way on the plate (25-30 minutes) in the first dimension
25) Dry the plate gently with a hair dryer for 10 minutes
26) Further separate the neutral lipids with a mixture of isopropylether:acetic acid (96:4, v:v) in the second dimension
27) Dry the plates gently with a hair dryer for 10 minutes
28) Spray the plates with primulin (in acetone-water 8:2, v:v)
29) Using the carrier lipids as markers, identify the lipid species, and scrape the desired lipids (in silica) into scintillation vials
30) Add 150 μl of water and 3 ml of scintillation fluid
31) Vortex each tube for 20 seconds 
32) Count radioactivity 
IP3 quantification by HPLC
Soluble Inositol Polyphosphate (IP) Extraction
1) Incubate MACS-enriched total B cells or FACS-purified B cell subsets (10x10
6/ml) in inositol-free DMEM containing 60 
mCi [
3H]Inositol/ml (Perkin Elmer) for 4 hours. 
2) Harvest cells, wash twice with 1 ml PBS and suspended in PBS (10x10
6/ml) in a glass tube.
3) Dispense 100 μl aliquots (1x10
6 cells) in 2.0 ml screw-cap polypropylene tubes.
4) Warm cells to 37°C for 5 min. Treat cells with 25 μl PBS with or without 20 μg/ml goat anti-mouse IgM F(ab’)
2 for 
desired time.
5) Stop treatments by adding 6.6 μl 10 N HCl and chilling cells instantly on ice. 
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6) Extract soluble IPs by adding 465 μl of chloroform/methanol (1:2 v/v). Vortex the mixture at maximum speed for 2 
minutes. 
7) Add 156 μl each of chloroform and 2 M KCl and vortex for another 2 minutes. 
8) Spin the lysate at 13,000 g for 5 minutes and the collect the supernatant in a screw-cap tube. Store at -20°C if needed.
Separation of IPs through HPLC
Analyze the samples by the HPLC (Shimadzu Corporation) connected to the Radio-HPLC Detector (IN/US Systems, Inc.). 
Sample preparation: Add ammonium phosphate (pH 3.5) to the supernatant (10 mM final). Filter through an Amicon Ultrafree-MC 
0.45 mm filter unit (Millipore). 
HPLC: Inject sample (500 ml) onto a Whatman partisphere SAX strong-anion exchange column (4.6 x 125 mm). Resolve the IPs 
by a linear gradient from 10 mM to 1.7 M ammonium phosphate (pH 3.5) for 25 minutes, followed by elution with 1.7 M 
ammonium phosphate for 20 minutes. For detection by an online Radio-HPLC detector, use Tru-Count (IN/US System) 
scintillation counting solution in 1:1 ratio. 
Calcium mobilization by FCM
Materials needed:
HBSS w/o phenol red (containing 10% FCS, 1mM Mg
++, with/without 1mM Ca
++)
Indo-1-AM (Molecular probes I-1223), resuspended at 1 mg/ml in DMSO
Anti-HSA-PE antibody (BD clone M1/69) 
Anti-CD23-biotinylated antibody (BD clone B3B4)
AA4.1-APC (e-bioscience 17-5892)
Non-indo-labeled cells to use for single stain controls for FCM
1) Rest MACS-enriched B cells on ice in complete RPMI for 1-2hrs
2) Wash cells, resuspend (10x10
6 cells/ml) in warm HBSS (without calcium), and load with indo-1-AM  (5μg/ml) for 30 
minutes in a humidified 37°C incubator.
3) Wash cells twice with HBSS 
4) Suspend cells (20x10
6 cells/ml) in FACS, and place on ice (reserve a small aliquot of indo-labeled cells to serve as the 
indo-1 single stain control for FCM)
5) Label remaining cells with biotinylated-CD23 (1:200 dilution) for 20 minutes (label single stain control cells as well)
6) Wash cells, and suspend (20x10
6 cells/ml) in FACS 
7) Label cells with HSA-PE (1:750 dilution), SAv-PerCP-Cy5.5 (1:200 dilution), and AA4-APC (1:100 dilution) for 20 
minutes (label single stain control cells as well)
8) Wash cells, and suspend (1x10
6 cells/ml) in HBSS (with calcium)
9) Keep on ice until assay
10) Warm cells for 15 minutes in a 37°C water bath prior to assay
11) Compensate the flow cytometer with single stain control cells
12) Load sample onto flow cytometer set to measure the ratio of Indo-1-violet/Indo-1-blue
13) Take baseline (non-stimulated) measurement for 30-90 seconds
14) Stimulate cells, and measure calcium ratio for 4-10 minutes
** To monitor calcium efflux from the ER without influx of extracellular calcium, use calcium-free HBSS when acquiring. 
Calcium can be added back in to monitor calcium influx.
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